The US government (rule-setter, via OMB M-22-18/M-23-16 and CISA's secure-software attestation form) converted informal 'we develop securely' into a recurring, signed, evidence-backed attestation required to sell software to federal agencies — the stick is exclusion from procurement, not a fine. The obligated class includes thousands of tiny ISVs and subcontractors with zero compliance staff. Signal 1431 adds a new evidentiary gap: AI co-authored commits have spoofable attribution on GitHub, so provenance of who/what wrote the code is now materially uncertain just as agent-driven development goes mainstream (signals 2085, 2175, 2096). The product: a subscription that plugs into GitHub/CI, continuously assembles the SSDF evidence file (branch protection, dependency/SBOM generation, build provenance, secret scanning results) plus a verified human-vs-AI commit-authorship ledger, and outputs an always-current attestation dossier a vendor can hand any agency or prime contractor. INFERENCE: primes will push the same demands down to subcontractors, multiplying the buyer class.

Cyber insurers (the rule-setters) have converted informal 'we have MFA and backups' claims into recurring, signed attestations where misstatement means denied claims or non-renewal — existential exclusion from insurability, not a fine. The obligated class is millions of SMBs with no compliance staff; their de facto IT department is an MSP. Signals 2070/2064/2057 show MSPs assembling security evidence ad hoc (SOC-style detection with no SIEM, hand-copied IR runbooks, backup posture in flux). The product: a white-label service sold through MSPs that continuously pulls evidence from M365/Entra, RMM, backup jobs, and EDR (MFA coverage, backup success logs, patch latency, IR runbook attestations per signal 2064's template demand) into a per-client, always-current, insurer-ready evidence file mapped to the common carrier questionnaires. MSPs resell it across their client book — exactly the pattern's consultant white-label channel. INFERENCE: insurers' questionnaire cycles function as the synchronized recurring duty.

Google (the rule-setter) is converting informal 'good app hygiene' into recurring, enforced, evidentiary duties: Android 17 enforces per-app memory limits with silent kills (signal 841) and mandates adaptive-UI compliance (signal 845), on top of annual target-SDK deadlines where the penalty is Play Store delisting or the app simply dying on devices — market exclusion, not a fine. The obligated class is hundreds of thousands of small studios and solo devs with no release/compliance function. The product: a subscription service that ingests each APK/AAB build via CI, runs memory-limit profiling, adaptive-UI checks, target-SDK/policy-deadline tracking, and Data-safety-form consistency checks, and maintains an always-current, per-app 'release compliance dossier' with evidence artifacts (profiler traces, screenshots across form factors, deadline calendar), alerting before Google's synchronized effective dates. This instantiates the pattern: numerous small operators + recurring documented duty + exclusion stick + evidence automatable from supplied builds.

Signal 2170 shows active DSA enforcement at the top (Meta breach finding). The DSA, however, also obliges non-VLOP hosting services and marketplaces to run notice-and-action processes, file a statement of reasons to the EU Transparency Database for every moderation decision, verify trader identities (KYBC), and publish transparency reports [INFERENCE: these duties come from the DSA text, not the signal]. That is a codified, recurring collect-verify-document-report duty on thousands of small EU forums, marketplaces, and community apps with no compliance staff; sanctions scale to turnover and enforcement momentum is now demonstrated by the Meta finding. The evidence format is literally standardized — the Transparency Database has one schema for everyone — satisfying the one-workflow-serves-thousands precondition by construction. Product: a per-site $50-200/mo subscription that plugs into the platform's moderation actions, auto-generates and files statements of reasons, maintains the KYBC trader file and notice-and-action log, and monitors the site's exposure (user thresholds, regulator correspondence) — 'DSA compliance file on autopilot' for operators far below where enterprise trust-and-safety vendors price.

Signal 1394 shows FDA codifying a class II special-controls pathway for opioid-impairment oxygenation monitors — a defined recurring duty set (special controls mean ongoing performance testing, labeling, adverse-event reporting, quality-system records) for anyone marketing such devices [FACT that the pathway exists; INFERENCE about the duty details]. Combined with the wearable/health-software signals, the target class is small AI-assisted health-device and SaMD builders whom this pathway newly invites into the market: solo or 2-5-person teams with no regulatory staff [INFERENCE]. The sanction is existential and non-negotiable — without cleared status and a maintained quality file, the product cannot legally be marketed, and import refusal/withdrawal is automatic. Incumbent eQMS vendors (Greenlight Guru, MasterControl) price at $15-50k+/yr for funded companies [INFERENCE], ignoring the tail. Product: a $200-400/mo subscription that scaffolds and continuously maintains the audit-ready file — design history, special-controls test evidence, complaint/MDR logs, submission-status monitoring — templated per device classification, starting with the new anesthesiology/monitoring codes where the special controls are freshly standardized and identical across all entrants.

Direct instantiation. Signal 2012 states India's DPDP Rules 2025 impose consent, breach-notification, and Data Fiduciary obligations on any SaaS processing Indian users' data, extraterritorially, with large penalties. These are recurring collect-verify-document duties (consent records per user, notice logs, breach-report trails, grievance handling) [FACT from signal for duty existence; INFERENCE for exact artifact list]. The obligated class is tens of thousands of micro/solo SaaS worldwide with Indian traffic and zero compliance staff [INFERENCE]. Incumbent consent/GDPR platforms price for enterprise and are not DPDP-specific [INFERENCE]. Product: a $29-99/mo per-product subscription that generates DPDP-compliant consent flows, continuously maintains the evidence file (consent ledger, notices in required formats, breach-notification runbook and clock, Data Fiduciary registers), and monitors regulatory status/deadlines — sold as 'your DPDP file, always audit-ready'. Note: the pattern's strongest form wants an existential/automatic sanction; DPDP's headline sanction is large fines plus potential government blocking of services in India [INFERENCE: blocking power beyond the signal text], which for SaaS with material Indian revenue approximates market death in that geography.

Transfer the pattern with the platform owner (Google) playing the regulator role [INFERENCE: adaptation of 'regulator' to platform gatekeeper, structurally equivalent]. Source signals state Android 17 makes adaptive-UI and memory requirements mandatory and that the system kills apps exceeding per-device RAM limits with no stack trace. That converts informal 'optimize your app' practice into a codified, recurring conform-verify-document duty; the obligated class is hundreds of thousands of small app developers with no platform-compliance staff [INFERENCE: population size]; the sanction is automatic and silent (OS kills the app; downstream Play target-API/quality delisting is existential). Product: a per-app subscription that (a) runs the app against each Android 17 device-RAM tier in emulator farms before every release, (b) ships a lightweight SDK that detects in-the-wild memory-limit kills (which produce no stack trace, so devs are blind), and (c) maintains an audit-ready 'platform compliance file' (adaptive-UI conformance, memory headroom per tier, Play policy status monitoring) priced at $20-100/mo — far below hiring an Android platform engineer.

Transfer the pattern with the vendor as regulator: Microsoft (signal 1729) and peer vendors (Google, Canva, Salesforce) impose recurring eligibility revalidation on nonprofits receiving donated/discounted licenses, and Microsoft just terminated the 365 Business Premium grant, forcing every affected org through a re-qualification and migration decision. The obligated class is perfectly enumerable — the IRS Business Master File and 990 e-file database list every US nonprofit with officers and addresses. The penalty is loss of access to the subsidized tooling the org runs on (INFERENCE: functionally existential for small nonprofits whose license value exceeds their IT budget — this is access-loss to an operational subsidy rather than literal market delisting, the weakest precondition here but structurally parallel). The product: a $30-60/mo bureau that tracks each org's grant portfolio, files annual revalidations, and executes license-optimization moves when programs change, sold via cold outbound cross-referencing the IRS file against the Business Premium termination.

Apply the pattern to FDA's device establishment registration and listing regime, made newly relevant to small software teams by signal 1394's class II special-controls pathway for opioid-impairment monitors (an area adjacent to wearables where solo-scale companies can now enter). Duties are recurring and evidentiary: annual establishment registration with fee, device listing updates, UDI/GUDID submissions, MDR adverse-event files. The obligated class is fully enumerable — FDA publishes the registration and listing database with company names and addresses. Penalty for lapse is misbranding: the device cannot legally be marketed and imports are refused — market-access loss. The product: a low-touch subscription that tracks each micro-firm's renewal windows, prepares filings, and monitors their listings for status changes, sold by cold outbound to the smallest registrants in the public database. INFERENCE: regulatory-affairs consultants price at $200-400/hr, unaffordable for two-person device startups.

Instantiate the pattern on the Chrome Web Store: the store imposes recurring duties on every extension developer (manifest-version migrations, permission re-justification, privacy-practices disclosures, periodic re-review after updates), enumerates every obligated entity publicly with a listed developer email, and punishes noncompliance with unpublishing — market-access loss, not a fine. Signal 2090 (PlugThis) shows extensions are increasingly generated by non-programmers who cannot self-serve compliance at all. The product: a subscription bureau that continuously lints a customer's manifest against current policy, drafts required disclosure updates, and alerts on policy changes affecting their specific permission set, with the prospect list built by crawling the store for extensions using deprecated APIs or missing disclosures. INFERENCE: no incumbent serves sub-$1k/yr extension publishers; agencies serve enterprises.

Transfer the pattern onto Google Play as the 'regulator': Play imposes recurring, evidentiary duties on every app developer (annual target-API-level uplift, Data Safety form accuracy, policy declarations, and now Android 17's adaptive-UI and enforced per-app memory requirements per signals 845/841), the store's own public catalog enumerates every obligated entity with a policy-mandated contact email, and the penalty is delisting/hiding — loss of market access, not a fine. The product is a survival-priced subscription ($15-40/mo) that watches each subscribed app: tracks every Play deadline, runs the app against Android 17 memory kill limits and adaptive-UI checks in emulators (signal 844 shows emulator-only testing is now viable), keeps Data Safety forms in sync with observed SDK behavior, and emails the developer a fix-it packet before each deadline. INFERENCE: the long tail of solo/abandoned-but-earning apps cannot staff this, and existing app agencies price for large publishers.

Transfer the pattern to small connected-health hardware/software makers: the FDA imposes recurring evidentiary duties on every device establishment — annual registration renewal in a fixed synchronized window (Oct 1–Dec 31), device listing updates, UDI submissions, MDR adverse-event files, and now special-controls documentation for newly classified categories like the opioid-impairment oxygenation monitor (signal 1394). The FDA publishes the complete Registration & Listing database with establishment names and contacts — a downloadable buyer roster. The sanction is existential and near-automatic: an unregistered establishment's devices are misbranded and cannot be legally marketed. The class II special-controls pathway in signal 1394, plus wearable-adjacent monitoring generally, is pulling small wearable/software teams into device-land with zero regulatory staff, while incumbent RA consultancies price for mid/large firms. Product: a $149-299/mo productized evidence-file subscription (renewal calendar + filing execution, listing/UDI upkeep, MDR log template maintenance, special-controls checklist for their device class), sold by emailing establishments in the public database whose renewal window is opening or whose listings look stale. INFERENCE: that enough micro-establishments exist in wearable-adjacent classes and will pay a subscription instead of a per-hour consultant; the duties, roster, and sanction are fact from FDA's published regime and the signal's classification rule.

Transfer the pattern with Microsoft-as-regulator: Microsoft is ending the free 365 Business Premium nonprofit grant, downgrading orgs to up to 300 Business Basic licenses (signal 1729). The obligated class — small nonprofits — is numerous, has no IT/compliance staff, and is publicly enumerated with contact info in the IRS Exempt Organizations Business Master File (downloadable) and state charity registries. The recurring duty is annual nonprofit eligibility re-verification with Microsoft plus ongoing license/tenant management; the sanction is loss of the tooling the org runs on (existential, auto-enforced at renewal). Product: a $49-149/mo subscription that maintains the org's Microsoft nonprofit eligibility file, executes the Premium-to-Basic transition (or cheapest compliant alternative), and patches the security gap Basic leaves (no Intune/Defender) with low-cost baseline hardening. Acquisition: cross-reference the IRS roster against orgs whose MX/SPF records show Microsoft 365 tenancy, then email the registered officer with their specific downgrade exposure. INFERENCE: that the grant change lands with a hard synchronized date and that small nonprofits will outsource this rather than absorb it; the roster, duty, and downgrade are fact per the signal and public IRS data.

Transfer the pattern with the CA/browser ecosystem as the regulator: Let's Encrypt is withdrawing its free expiry-notification emails (signal 1845), while the recurring duty (renew every 90 days, soon shorter as browsers push shorter cert lifetimes) and the existential auto-enforced sanction (browsers hard-block the site — total loss of market access) remain. The public roster is Certificate Transparency logs: a complete, machine-readable, legally-mandated enumeration of every certificate holder, domain, and expiry date. Product: a $5-15/mo per-org monitoring subscription (expiry alerts across all certs found in CT for your domains, renewal-failure detection, escalation via email/SMS/Slack), acquired by watching CT for certs entering their final 14 days with no reissued successor and contacting the domain's published contact. INFERENCE: cert monitoring tools exist, but none use the CT roster as a direct-outreach buyer list timed to the Let's Encrypt notification shutdown; the novelty is the GTM engine plus positioning as the drop-in replacement for the withdrawn free safety net.

Transfer the pattern with Google-as-regulator: Android 17 introduces mandatory adaptive-UI and per-app memory requirements (signals 845, 841), stacking on top of Google Play's existing annually-ratcheting target-API-level deadlines and data-safety/permission declarations. The obligated class is millions of small app developers with no compliance staff; the roster is the Play Store itself — every listing is publicly crawlable and carries a mandatory public developer contact email; the sanction is auto-enforced loss of market access (apps are hidden from new users, then removed, without human review). Product: a $29-99/mo subscription that continuously scans a developer's published apps against the current and announced Play requirement set (targetSdk deadline, Android 17 adaptive-UI/memory readiness, declaration renewals), maintains the evidence file (test artifacts, declaration history, deadline calendar), and alerts with concrete remediation steps. Customer acquisition: crawl Play for apps whose manifests/listings show stale targetSdk or missing Android 17 readiness, and email the publicly listed developer address with their specific delisting date. INFERENCE: that developers will pay a monitoring subscription rather than react ad hoc; the recurring-duty structure and auto-enforced sanction are fact from the signals and Play's published policy mechanics.

FACT (signal 2170): the EU Commission formally found Instagram and Facebook in breach of the DSA, demonstrating active enforcement. INFERENCE: the DSA obligates not just VLOPs but thousands of small EU hosting services, forums, and niche marketplaces to run notice-and-action mechanisms, file a statement of reasons to the Commission's Transparency Database for every moderation action, and publish transparency reports — a recurring, evidentiary duty imposed on operators with no compliance staff, where sustained non-compliance risks orders that end EU market access. Product: a subscription middleware that plugs into a small platform's existing moderation tooling (Discourse, custom admin panels, marketplace dashboards via webhook/API), auto-generates and submits compliant statements of reasons, maintains the notice-and-action audit log, and compiles the annual transparency report — an always-current DSA evidence file for platforms with 1-10 staff. This instantiates the pattern's structure directly; the Meta ruling is the fear-inducing enforcement signal that converts awareness into purchases.

FACT (signal 2012): India's DPDP Rules 2025 impose consent, breach-notification, and Data Fiduciary obligations on any SaaS processing Indian users' data, with extraterritorial reach and large penalties. INFERENCE: enforcement includes the Data Protection Board's ability to effectively cut off the Indian market (blocking/orders), and the obligated class is exactly the pattern's long tail — tens of thousands of small SaaS teams worldwide with Indian users and zero compliance staff, facing a synchronized phase-in date. Product: not another consent-banner tool, but a subscription 'DPDP evidence vault' that continuously assembles the audit-ready dossier the Rules actually demand — timestamped consent records mapped to processing purposes, grievance-officer response logs, breach-notification drill records, data-retention proofs, DPA registry of processors — auto-populated from the SaaS's existing stack (auth provider, support desk, cloud logs) and exportable as a single defensible file when the Board or an enterprise customer asks. Instantiates the pattern: rule-setter converts informal data handling into a recurring documented duty; exclusion from the Indian market is the stick; evidence assembly is automatable from supplied records.

FACT (signals 1883, 2066): grid power quality is measurably degrading (700% YoY rise in UPS power-quality alerts across multi-state sites) and MSPs already want UPS battery health exposed through monitoring portals. INFERENCE: small accredited healthcare facilities (surgery centers, dialysis clinics, nursing homes) carry a recurring, evidentiary duty — NFPA 110/99 and accreditor-mandated generator/UPS test logs, monthly load tests, battery inspections — where the penalty is loss of accreditation and therefore Medicare/insurer participation: market exclusion, not a fine. They have no compliance staff; the facility manager is the forced buyer. Product: a subscription that ingests telemetry from networked UPS/ATS/generator controllers (or technician photo/attestation uploads where telemetry is absent), auto-assembles the always-current, surveyor-ready emergency-power evidence dossier, and flags missed tests before a survey does. This instantiates the pattern: rule-setter (accreditors/NFPA/CMS) + numerous small operators + recurring evidence duty + exclusion stick + automatable assembly from monitored device data.

FACT (signals 845, 841): Android 17 makes adaptive-UI and per-app memory limits mandatory, and the system silently kills apps that exceed RAM budgets with no stack trace; Google already imposes recurring duties (annual target-API deadlines, data-safety declarations, policy attestations) where the penalty is delisting/being hidden from Play — market exclusion, not a fine. INFERENCE: this converts app maintenance from an informal practice into a recurring, evidentiary compliance duty for millions of solo devs and small studios with no compliance staff, exactly instantiating the pattern. Product: a $19-49/mo subscription that continuously runs each app against Android 17 memory ceilings across simulated device RAM tiers, tracks target-API/policy/declaration deadlines via the Play Developer API, and maintains an always-current 'Play compliance dossier' (test evidence, vitals trends, declaration history) plus early-warning alerts — so a solo dev can prove and preserve their listing the way a bar owner keeps a liquor license file.

FACT (signal 1394): the FDA created a class II special-controls pathway for opioid-impairment oxygenation monitors, an area adjacent to wearables where software matters. This instantiates the pattern: a defined pathway converts market entry into codified recurring duties — annual establishment registration and device listing (INFERENCE: lapse renders devices misbranded, an automatic status-loss), Medical Device Reporting on adverse events, UDI maintenance, and the ongoing performance/documentation requirements the special controls themselves mandate. The obligated class is a long tail of small hardware/software startups this de-risked pathway will specifically attract (that is its purpose), none of whom can afford a regulatory hire; sanctions (import refusal, registration lapse, recall) are government-controlled and existential. Evidence is standardizable because every entrant under the same product code faces the identical special-controls checklist. The product: a per-company $200-500/mo subscription that maintains the living evidence binder mapped to the named special controls (design docs, verification records, complaint log, MDR decision trail), tracks the annual registration/listing clock, and monitors the company's FDA registration and warning-letter status. INFERENCE: eQMS incumbents (Greenlight Guru, MasterControl) price at $10k+/yr for funded mid-market companies, leaving the solo/seed tail unserved — the pattern's pricing gap.

FACT (signal 2012): India's DPDP Rules 2025 impose consent, breach-notification, and Data Fiduciary obligations on any SaaS processing Indian users' data, with extraterritorial reach and large penalties. This instantiates the pattern: recurring duties (verifiable consent records per user, consent-manager integration, breach-notification readiness, grievance handling, periodic data-minimization review), an obligated class of tens of thousands of small non-Indian SaaS teams who have no Indian counsel or compliance staff, and a sanction that is more than a negotiable fine — INFERENCE: India's enforcement toolkit includes ordering ISP-level blocking of noncompliant foreign services, i.e., loss of the entire Indian market, and penalties up to ~₹250 crore make single violations existential for a micro-SaaS. The evidence format is standardizable: the same consent-artifact schema, notice templates, and breach-response runbook serve every small B2C/B2B SaaS. The product: a $49-149/mo subscription that generates the India-specific compliance file (consent records store, DPDP-compliant notices in required languages, breach-notification templates with the statutory clock), monitors rule deadlines and enforcement actions, and produces the audit-ready dossier on demand. Incumbents (OneTrust et al.) price consent management for enterprises, ignoring the tail — matching the pattern's incumbent-gap precondition.

Transfer the pattern with the platform, not a government, as the regulator — the sanction structure is identical. FACT (signals 841, 845): Android 17 introduces enforced per-app memory limits where the OS silently kills over-limit apps with no stack trace, plus mandatory adaptive-UI requirements forcing ecosystem-wide app updates; Google Play separately enforces target-SDK deadlines with automatic delisting/hiding. This instantiates the pattern: recurring codified duties (every OS release + annual target-SDK ratchet), an obligated long tail of hundreds of thousands of solo/small studios with no platform-compliance staff, an automatic and silent penalty (kills with no crash report; store removal) that equals market death, and a standardizable evidence workflow (same Play policies and OS limits apply to every app). The product: a $30-100/mo per-app subscription combining an on-device SDK that detects and reports Android 17 memory-kill events from the field (INFERENCE: detectable via ApplicationExitInfo-style APIs on next launch), pre-release checks against the current mandatory-requirements checklist, and continuous monitoring of the app's Play listing status and upcoming policy deadlines — maintaining the 'audit-ready file' that proves the app meets platform mandates.

Transfer the pattern to the DSA's obligations on NON-giant intermediaries. FACT (from signal 2170): the Commission has issued a formal breach finding against Meta, demonstrating active DSA enforcement. FACT (background law the signal points at): the DSA obliges every hosting service serving the EU — including small forums, marketplaces, and SaaS with UGC — to file a machine-readable statement of reasons to the EU Transparency Database for every content-moderation action, publish periodic transparency reports, and run notice-and-action workflows. This instantiates the pattern exactly: a regulator converted informal moderation into recurring collect-document-report duties; the obligated class is tens of thousands of small operators with zero compliance staff; the evidence format is literally standardized (the Transparency Database has one JSON schema for everyone); the ultimate sanction is 6%-of-turnover fines and, for persistent breach, EU access blocking. INFERENCE: incumbent trust-and-safety vendors (Tremau, Checkstep) price for mid/large platforms, leaving the tail unserved. The product: a $50-200/mo plug-in that hooks a small site's moderation actions (Discourse, WordPress, custom via API), auto-generates and submits compliant statements of reasons, accumulates the audit-ready transparency-report file, and monitors for regulator contact/DSA status changes.

As banks and fintechs institutionalize onchain money movement (signals 864, 868, 598), more small operators — crypto ATM owners, remittance agents, payment resellers — fall under Money Services Business rules. Duties are recurring and evidentiary: biennial FinCEN registration renewal, a maintained written AML program, periodic independent AML reviews, agent-list updates, and state license renewals. The penalty is loss of market access: lapsed registration means banks debank the operator and processing partners cut them off (and unregistered operation is itself unlawful). FinCEN's public MSB Registrant Search is a downloadable list of every obligated entity with name, address, and MSB activity type. Transfer the pattern as a $99-299/mo bureau that calendars the biennial renewal, maintains the AML program document against rule changes, brokers the required independent review, and produces the bank-ready compliance packet — cold outbound straight from the FinCEN list. INFERENCE: incumbent AML consultancies price for banks and mid-size fintechs; single-location MSBs are unserved.

Microsoft ending the free 365 Business Premium nonprofit grant (signal 1729) reveals the structure: platform vendors (Microsoft, Google, TechSoup-brokered programs) impose recurring eligibility revalidation, license true-ups, and migration deadlines on nonprofits; the penalty is loss of licenses — staff locked out of email and files, i.e. loss of operational access, not a fine. The obligated class is perfectly enumerable: the IRS Publication 78 / Business Master File publicly lists every 501(c)(3) with EIN and address, and an MX-record lookup on each org's domain identifies which ones run on Microsoft 365 vs Google — a downloadable, pre-qualified prospect list. Transfer the pattern as a $49-149/mo bureau that tracks every grant program's revalidation calendar, files the annual eligibility paperwork, optimizes the license mix (e.g. the 300 free Business Basic fallback plus paid security add-ons), and executes forced migrations. INFERENCE: MSPs price nonprofit work at levels only mid-size orgs can afford; sub-20-staff nonprofits are unserved.

The FDA's new class II special-controls pathway for opioid-impairment oxygenation monitors (signal 1394) exemplifies a wave of small wearable/software-adjacent device makers entering FDA jurisdiction. Every device establishment must complete recurring duties: annual establishment re-registration (fixed Oct-Dec window) with fee, device listing updates, GUDID/UDI data maintenance, MDR adverse-event logging, and special-controls documentation. Noncompliance renders the device misbranded — import refusal and removal from market, not a fine. The FDA's public establishment registration & device listing database enumerates every obligated entity with name and address. Transfer the pattern as a low-touch subscription bureau ($200-500/mo) that calendars and files the annual re-registration, maintains listings/UDI records, and templates the special-controls evidence file — cold outbound to establishments in the public DB with only 1-2 listed devices. INFERENCE: regulatory consultants charge $10k+ engagements priced for mid-size medtech, leaving one-device startups unserved.

Google is the 'regulator': Android 17 imposes recurring, evidentiary duties on every published app — annual target-API-level upgrades, new mandatory adaptive-UI support, per-app memory limits that silently kill non-compliant apps (source: signals 845, 841), plus recurring data-safety-form and policy re-attestations. The penalty is delisting/removal from Play, i.e. loss of market access, not a fine. The Play Store itself is the regulator-maintained public database enumerating every obligated entity: each listing exposes developer name, contact email, and (under EU DSA trader rules) address. Transfer the pattern as a survival-priced subscription ($29-99/mo) that monitors each subscriber's apps against every upcoming Play deadline, files/updates the recurring attestations, runs target-SDK and memory-limit conformance checks on each release, and delivers the evidentiary trail — sold cold-outbound to the millions of small developers whose apps earn money but who have no compliance function. INFERENCE: incumbent help is agencies priced for enterprises; the long tail is unserved.

Transfer the pattern with browsers/CAs as the enforcing regulator. Recurring duty: renew TLS certificates every 90 days (Let's Encrypt), with the free evidentiary safety net — LE's expiry emails — being withdrawn per the signal. Sanction is perfectly auto-enforced and existential: an expired cert makes browsers block the site, i.e., instant loss of market access. The obligated class is numerous, small, and publicly enumerated in a way most compliance markets never are: Certificate Transparency logs are a complete, downloadable roster of every certificate holder, domain, and expiry date. INFERENCE: a $5–20/mo expiry-monitoring/auto-renewal-verification subscription sold by targeted outreach to domains whose CT-log record shows an expiring cert with no successor issued — contacting them days before breakage — instantiates the pattern with near-zero CAC. The novelty is the roster-driven GTM (monitoring tools exist but wait for inbound; none mine CT logs to reach lapsing operators at the moment of maximal pain).

Treat Google Play as the regulator. Recurring evidentiary duties: annual target-API-level upgrades, data-safety form accuracy, and now Android 17's mandatory adaptive-UI support and enforced per-app memory limits (apps exceeding limits are killed with no stack trace). The obligated class — long-tail solo/small app developers — is publicly enumerated: Play listings expose developer name and (under EU DSA trader rules) contact details, and the catalog is scrapeable to find apps targeting stale SDKs or not updated in 18+ months. Sanction is auto-enforced loss of market access: Play hides/removes apps below the required target API, and Android 17 memory kills silently destroy retention. INFERENCE: a $99–199/mo 'keep-my-app-listed' subscription (SDK bump, adaptive-UI patch, memory profiling against the new limits, data-safety refresh) sold by direct outreach to scraped at-risk developers instantiates the roster-subscription pattern; the annual Play deadline plus the Android 17 effective date is the synchronized demand spike.

Transfer the pattern onto FDA-registered small device establishments. Regulator-imposed recurring duties: annual establishment registration renewal (with fee, Oct 1–Dec 31 window), device listing updates, UDI data, MDR complaint files, and — per the new June 2026 class II classification for opioid-impairment oxygenation monitors — ongoing special-controls evidence (performance testing, human-factors, labeling files). The obligated class is publicly enumerated: FDA's establishment registration & listing database is downloadable and includes firm names and official-correspondent contacts. Sanction is existential and auto-enforced: an unrenewed registration renders the device misbranded and delistable from market. Incumbent RA/QA consultancies price for mid/large firms. INFERENCE: a productized $200–500/mo 'FDA evidence file' service (renewal calendar, listing hygiene, MDR log, special-controls binder) sold by direct outreach to single-listing establishments instantiates the pattern; the new special-controls pathway adds a synchronized demand spike as small teams enter via that route.

The FDA's classification of opioid-impairment oxygenation monitors under a class II special-controls pathway (signal 1394) is the rule-setter move: it invites small wearable/SaMD teams into the market while imposing recurring evidentiary duties — design-control files, software documentation, post-market complaint handling, MDR-reportable-event logs — where the penalty is losing clearance, i.e., total market exclusion. INFERENCE: as more device categories get special-controls pathways, the obligated class becomes many small hardware/software startups with no regulatory staff; a subscription that maintains an always-current, auditor-ready special-controls binder (templated to the specific classification regulation, auto-ingesting complaint tickets, version-control logs, and test evidence from GitHub/Jira) instantiates the pattern at 1/20th the cost of a regulatory consultant retainer.

Google is the rule-setter converting informal app maintenance into recurring auditable duties: Android 17 makes adaptive-UI and per-app memory limits mandatory, silently killing non-compliant apps with no stack trace (signals 845, 841), on top of annual target-API deadlines where the penalty is delisting — market exclusion from the only store that matters. The obligated class is millions of solo/small developers with no release-engineering staff. INFERENCE: a subscription that continuously tests each app build against the current mandate set (memory-limit simulation on target RAM classes, adaptive-UI checks, policy-declaration diffs) and maintains a timestamped 'compliant as of' evidence file with fix-it tickets instantiates the pattern; synchronized OS/policy deadlines create quarterly forced-buyer waves.

Cyber-insurance carriers and the FTC Safeguards Rule have converted informal SMB security hygiene into recurring, attestation-backed duties (MFA proof, backup verification, IR plans, log retention) where the penalty is denied coverage or denied claims — market exclusion for the SMB. The signals show MSPs manually assembling exactly this evidence (IR runbooks id 2064, backup posture id 2057, SOC-lite monitoring id 2070) with no compliance staff. INFERENCE: a subscription service that auto-assembles a per-client, always-current insurance-renewal evidence dossier (pulling from RMM/M365/backup APIs, storing signed attestations and runbook-review timestamps) instantiates the pattern, with MSPs as the white-label channel across their client books — matching the pattern's secondary monetisation channel exactly.

Signal 1394 codifies a class II special-controls pathway for opioid-induced-impairment oxygenation monitors — converting an informal space (wellness wearables, remote monitoring apps) into codified recurring duties for anyone entering it: conformance to named special controls, design-history documentation, post-market surveillance, MDR adverse-event reporting, and cybersecurity documentation, with the sanction being refusal or withdrawal of clearance — market death, since selling without it is illegal. The pattern transfers because the entrants attracted by a defined pathway are small wearable/software teams (the adjacency signal 529 shows the consumer-wearable world these builders come from), not pharma-scale companies with RA/QA staff. Product: a subscription evidence layer purpose-built for software-centric class II special-controls devices — a living technical file mapped to the specific special controls in the classification order, automated logging of verification/validation runs as design-history evidence, and monitoring of FDA guidance/recall databases affecting the device class. Priced per device family, far below a regulatory consultant retainer. INFERENCE: that this rule pulls in multiple small entrants (population size) is inferred from the defined-pathway effect, not stated; the recurring nature of QMS/post-market duties is FACT of the class II regime.

Signal 2170 shows DSA enforcement escalating at the top (Meta breach finding), but the DSA also imposes recurring duties on thousands of small non-VLOP platforms serving EU users: notice-and-action mechanisms with statements of reasons filed to the EU transparency database, annual transparency reports, a designated point of contact, and trader traceability (KYBC) for marketplaces — where failure to collect trader data means the marketplace must delist the seller, an automatic sanction, and platform-level noncompliance risks blocking orders. Product: a per-platform subscription that instantiates the pattern — a drop-in moderation-decision logger that auto-formats and submits statements of reasons, assembles the annual transparency report from the same log, maintains the KYBC dossier per trader, and monitors enforcement signals (Commission/DSC actions like 2170) that reprioritize duties. The obligated class (indie forums, niche marketplaces, community apps with EU users) is far below where DSA compliance consultancies price. INFERENCE: that small platforms are currently non-compliant and unserved is inferred from the enforcement focus on VLOPs to date, not stated in the signals.

Transfer the pattern with the insurance carrier as the quasi-regulator. Carriers have converted informal security posture into codified recurring collect-verify-document duties: annual/renewal attestations of MFA coverage, EDR deployment, backup testing, and a written incident-response plan — and the sanction is automatic and existential: claim denial or non-renewal, i.e. the SMB is uninsured and loses contracts requiring coverage. The obligated class is millions of SMBs with no security staff, reached through MSPs (signals 2064, 2070, 2057 show MSPs improvising runbooks, detection, and backup evidence by hand). Product: a per-client subscription evidence vault the MSP resells — continuously pulls proof from M365/RMM/backup tools (MFA state, EDR agent coverage, restore-test logs), maintains the IR runbook (directly answering signal 2064's request), and generates the renewal questionnaire answers with linked evidence so a denied claim can be contested. INFERENCE: carrier questionnaires are standardizable across SMBs (they converge on the same ~40 controls) — inferred from industry practice, not from the source signals.

Transfer the pattern onto Google Play as the 'regulator'. Android 17 and Play policy convert informal app maintenance into codified recurring duties: annual target-API-level deadlines, Data Safety form accuracy, adaptive-UI and per-app memory-limit conformance (signals 845, 841), each enforced by automatic sanctions — apps are hidden, blocked from updates, or removed with no negotiation, and Android 17 kills over-budget apps silently with no stack trace. The obligated class is hundreds of thousands of solo/small app publishers with no compliance or release-engineering staff. Product: a per-app subscription that (a) maintains the audit-ready evidence file (policy declarations, SDK/data-flow inventory backing the Data Safety form, target-API and memory-budget conformance reports per release) and (b) continuously monitors the status itself — Play policy changes, deadline countdowns, memory-kill telemetry — alerting before the automatic penalty fires. INFERENCE: that small publishers will pay a monitoring subscription is inferred from the pattern's economics, not stated in the signals; the automatic-removal enforcement of target-API deadlines is established Play behavior (inference from platform history, consistent with signal 845's 'forces app updates ecosystem-wide').

The EU Commission's DSA breach finding against Meta (signal 2170) shows active enforcement. The DSA imposes recurring evidentiary duties on every non-micro online platform serving the EU — not just VLOPs: a machine-readable statement of reasons filed to the Commission's public DSA Transparency Database for every moderation action, periodic transparency reports, notice-and-action logs, and a designated legal representative. The Commission's own Transparency Database publicly enumerates submitting platforms, and platforms that should file but don't are identifiable by comparing app-store/marketplace listings against the database — a regulator-anchored prospect list. Sanctions escalate from fines to interim measures and ultimately access restriction in the EU (market exit). INFERENCE: DSA compliance offerings today are consultancy-priced for VLOPs, leaving thousands of mid-sized forums, marketplaces, and niche UGC apps unserved. Product: a $99–299/mo bureau providing SoR API submission tooling, auto-generated transparency reports from moderation logs, and notice-and-action recordkeeping — the pattern transferred onto mid-tail EU platforms.

Signal 1394 establishes a class II special-controls pathway for opioid-impairment oxygenation monitors — an area adjacent to wearables where small software-led teams will enter. FDA imposes recurring evidentiary duties on every device firm: annual establishment registration renewal, device listing updates, 30-day MDR adverse-event reports, complaint files, and special-controls documentation. Penalty is misbranding/adulteration → the device cannot be legally marketed and imports are refused — loss of market access. The obligated class is enumerable from FDA's own public Establishment Registration & Listing database (with addresses) plus the 510(k)/De Novo clearance databases. INFERENCE: incumbent eQMS vendors (Greenlight Guru, MasterControl) price at $10k+/yr for funded companies, leaving single-establishment micro-manufacturers unserved. Product: a $199–399/mo low-touch service handling registration renewal, listing updates, MDR eSubmitter filings, complaint-log templates, and a per-product-code special-controls checklist — the pattern transferred onto medical-device micro-manufacturers with the FDA database as the prospect list.

Google acts as the 'regulator': it imposes recurring, evidentiary duties on every Play Store developer (annual target-API-level deadline, Data Safety form accuracy, policy declarations, and per signals 845/841 the new Android 17 mandatory adaptive-UI and enforced per-app memory limits that silently kill noncompliant apps). The penalty is delisting/hiding from the Play Store — loss of market access, not a fine. The obligated class is fully enumerable: the Play catalog is publicly crawlable and every listing is required to display a developer contact email, so the prospect list is downloadable. INFERENCE: incumbent app-compliance/consulting is priced for studios, leaving millions of small/solo developers unserved. Product: a $19–49/mo subscription that continuously audits each app against upcoming Play policy deadlines, flags lagging targetSdk, estimates Android 17 memory-kill exposure via an exit-info SDK, drafts Data Safety form updates, and alerts before each delisting window. This instantiates the pattern exactly: recurring duty + public enumeration of obligated entities + existential (delisting) penalty + survival-priced subscription sold via cold outbound to the regulator-maintained list.

Signal 2012 states India's DPDP Rules 2025 impose consent, breach-notification, and Data Fiduciary duties on any SaaS touching Indian users, with extraterritorial reach and large penalties. Pattern transfer: the obligated class (small SaaS and app teams with Indian users) is enumerable through public rosters — app-store listings geo-available in India with their mandated data-safety declarations and developer contacts, plus startup directories. The duties are recurring, not one-time: maintaining verifiable consent records, current-language privacy notices, grievance-officer publication, and breach-notification readiness. Sanction: heavy penalties plus, INFERENCE, blocking orders against non-compliant services in India function as loss of market access. Incumbents (privacy law firms, OneTrust-class tooling) price for enterprises. Product: a low-cost monthly 'DPDP evidence vault' — templated consent-record ledger, notice/grievance-page generator, breach-response runbook kept current with the phased rule deadlines — sold by direct outreach to small teams identified from India-visible app/SaaS listings, with the phased compliance deadlines as the demand spike.

Signals 845/841 state Android 17 introduces mandatory adaptive-UI and enforced per-app memory limits (apps exceeding them are killed with no stack trace), and major releases force ecosystem-wide updates. Pattern transfer: Google Play acts as the 'regulator' — it imposes recurring duties (annual target-SDK deadline, policy declarations, data-safety form accuracy, now Android 17 behavioral requirements) on millions of small publishers, and the Play Store itself is the public, enumerable roster: every listing exposes the developer's mandated contact email (and, for EU trader status under the DSA, a physical address). The sanction is auto-enforced loss of market access: apps behind target-SDK requirements are hidden or removed from Play. INFERENCE: existing tooling (analytics, ASO suites) serves large publishers; solo devs have no one maintaining their 'stay-listed' evidence. Product: a monthly per-app retainer that continuously tests the app against upcoming Play/Android 17 requirements (memory-limit telemetry runs, adaptive-UI checks, target-SDK countdown, data-safety drift) and delivers an evidence file plus remediation alerts, sold by scraping Play for apps with stale targetSdkVersion and emailing the listed developer contact.

Signal 1394 shows FDA opening a class II special-controls pathway for opioid-impairment oxygenation monitors, which will pull small wearable/software teams into FDA-regulated territory. Pattern transfer: FDA already imposes recurring evidentiary duties on every device establishment (annual registration renewal each Oct-Dec, device listing updates, complaint files, MDR event logs, UDI/GUDID records), and FDA publishes a complete, downloadable Registration & Listing database of every establishment with names and addresses — a ready-made roster of obligated small operators. The sanction is existential and auto-enforced: an unrenewed registration renders devices misbranded, triggering import refusals and market removal. INFERENCE: incumbents (RA/QA consultancies) price for mid/large medtech, leaving one-product startups (like new special-controls entrants) unserved. Product: a $300-600/mo 'FDA evidence file' subscription — registration/listing renewal management, complaint-file and MDR log maintenance, audit-ready binder — sold by direct outreach to small/new establishments pulled from the public database, with the annual Q4 renewal window acting as the synchronized demand spike.

The FDA's class II special-controls classification for opioid-impairment oxygenation monitors (signal 1394) is the rule-setter move: it converts an unregulated wearable-adjacent product category into a defined, recurring evidentiary regime — design controls, software V&V documentation, human-factors files, adverse-event reporting, postmarket surveillance — where the stick is pure market exclusion (you cannot legally sell without clearance and a maintained QMS). The newly obligated class is small hardware/wearable startups (the same builders signals 529/1394 describe) with no regulatory staff, facing $150k+ consultants or $20k+/yr mid-market QMS suites. INFERENCE: a low-cost subscription that generates and maintains the audit-ready special-controls dossier for this ONE device category — templated V&V evidence bound to the specific special controls in the rule, auto-tracked design-change and complaint logs — instantiates the pattern as a narrow wedge, then repeats per new special-controls classification the FDA publishes.

Google is the rule-setter converting 'keep your app working' into recurring documented duties: Android 17 enforces per-app memory limits with silent kills and mandatory adaptive UI (signals 845, 841), on top of annual target-SDK deadlines and Play data-safety declarations — and the penalty is delisting or an app that the OS kills without a stack trace, i.e., market exclusion. The obligated class is millions of solo/small app developers with no release-engineering staff. INFERENCE: a subscription CI service that runs each build against the current mandate set (memory ceiling profiling on emulated RAM tiers, adaptive-UI checks, target-SDK/policy deadline tracking) and maintains an always-current 'Play-readiness dossier' — proof of compliance plus early warning when a new Android release adds duties — instantiates the pattern: recurring evidentiary duty, staff-less operators, automatable from supplied artifacts (the APK/AAB).

Cyber-insurance carriers have become de-facto rule-setters: annual renewal attestations (MFA everywhere, tested backups, EDR, documented incident-response plans) are a recurring, evidentiary duty imposed on millions of SMBs, and a false attestation voids coverage — while many SMB contracts (healthcare, gov subcontracts) require active coverage, making loss of insurability market exclusion. The signals show the raw evidence already exists inside MSP tooling but is never assembled: backup/BCDR job logs (2057), Windows security telemetry (2070), IR runbooks being begged for (2064). INFERENCE: a subscription service that pulls from RMM/M365/backup APIs and continuously renders a carrier-ready evidence dossier (control attestations with timestamped proof, IR plan, restore-test log) instantiates the pattern, with the white-label-through-MSPs channel the pattern explicitly predicts — one MSP resells it across 50-200 clients.

The DSA converts informal content moderation into recurring, documented duties for EVERY hosting service and online platform in the EU, not just Meta: logging each moderation decision, sending statements of reasons to the Commission's transparency database, publishing annual transparency reports, and maintaining notice-and-action records. The rule-setter (EU Commission, now visibly enforcing per the Meta breach finding) imposes this on thousands of small marketplaces, forums, SaaS-with-UGC, and niche app stores that have zero compliance staff; the stick is fines up to 6% of turnover and ultimately restriction of EU access. INFERENCE: a subscription service that plugs into a platform's moderation actions (API/webhook), auto-generates and files statements of reasons, accumulates the audit trail, and renders the annual transparency report instantiates the pattern exactly — always-current evidence file, trivial cost vs. existential risk. The Commission's public statement-of-reasons database makes the required output format fully automatable.

The FDA's new class II special-controls classification for opioid-impairment oxygenation monitors (signal 1394) is one instance of a broader move: defined special-controls pathways invite small hardware/software teams (adjacent wearable signal 529) into regulated territory, then bind them to recurring collect-verify-document-report duties — design history file, software documentation per special controls, complaint handling, MDR adverse-event reporting, postmarket surveillance. The obligated class is a growing long tail of small digital-health/wearable builders with no RA/QA staff; the sanction is existential and largely automatic (no clearance → cannot market; failed audit → recall/import refusal). INFERENCE: incumbents (Greenlight Guru, MasterControl) price eQMS at $10k-40k/yr for funded companies; a $200-500/mo pathway-specific evidence-file subscription — templated to a named special-controls rule, auto-maintaining the audit binder as the product iterates, monitoring FDA registration/listing status and MDR deadlines — serves the tail one workflow at a time, starting with this exact monitor classification as the wedge.

Pattern instantiation with a platform as the regulator: Android 17 (signals 845, 841) converts informal 'good memory hygiene' into a codified, enforced duty — per-app memory ceilings based on device RAM, with automatic, silent kills (no stack trace) as the sanction, plus mandatory adaptive-UI requirements tied to Play distribution. The obligated class is the long tail of hundreds of thousands of indie/small-studio apps with no performance-engineering staff; the penalty is effectively existential (app silently dies on users' devices → 1-star reviews → ranking death; targetSdk noncompliance → Play delisting). INFERENCE: a subscription service that continuously runs each release build across an emulated device-RAM matrix, produces the standardized 'evidence file' (memory profile per device class, headroom trends, adaptive-UI conformance report), and monitors the live status (ANR/silent-kill vitals, Play policy deadlines) fills the gap below enterprise APM (Datadog/Embrace price out indies). Solo-buildable: emulator farm + existing profiling APIs, 30-60 days.

The DSA breach finding against Meta (signal 2170) confirms the Commission is now actively enforcing the DSA, whose Article 30/31 trader-traceability ('Know Your Business Customer') duties also bind thousands of small niche marketplaces (craft, collectibles, B2B parts, local-services platforms), not just VLOPs. Pattern instantiation: regulator (EU Commission/DSCs) converts informal seller onboarding into codified collect-verify-document duties (trader identity, payment, registry entries, self-certification, random re-checks); the obligated class is long-tail marketplace operators with no compliance staff; the sanction is being ordered to suspend traders or facing fines that kill a thin-margin marketplace. INFERENCE: a per-marketplace subscription that builds and continuously maintains the audit-ready trader-vetting file (automated registry lookups, document collection, re-verification scheduling, suspension logs, regulator-ready export) can be priced at €100-300/mo — far below a compliance hire — and built solo using agent tooling (signals 2179, 2096) in 60-90 days.

Instantiate the pattern with Microsoft's nonprofit program as the quasi-regulator. Signal 1729: Microsoft is ending the free Business Premium grant and replacing it with up-to-300 Business Basic licenses gated by org size and continued eligibility. The duty is recurring: nonprofits must periodically revalidate charitable status, keep license assignment within grant rules, and now execute a forced migration/downgrade without losing security posture (Basic lacks Intune/Defender). The penalty is loss of access — the grant (their email, files, identity stack) is shut off — not a fine. The obligated class is enumerable from public records: national charity registers (IRS EO BMF in the US) list every nonprofit with size proxies (revenue) and contact info, and eligibility rules map directly onto those fields. Incumbent MSPs price per-seat management for larger orgs; sub-25-seat charities are unserved. Product: a $25-75/mo bureau that tracks grant-policy changes, handles revalidation paperwork, right-sizes license mix at renewal, and bundles the cheap security add-ons Basic lacks — sold by cold outbound to small charities identifiable in the IRS file as being in the affected band. INFERENCE: which orgs currently hold Microsoft grants is not public, so targeting is probabilistic (all small charities, not confirmed grant holders) — this weakens but does not break the CAC-collapse mechanic; the policy change itself is fact per the signal.

Apply the pattern to FDA-regulated small device makers. The duties are recurring and evidentiary: annual establishment registration and device listing, UDI/GUDID data maintenance, Medical Device Reporting, and — for new special-controls class II categories like the opioid-impairment oxygenation monitor in signal 1394 — ongoing labeling and performance documentation. The penalty is market-access loss: an unregistered/unlisted device is misbranded and cannot legally be sold, and FDA import alerts physically block product at the border. The obligated class is enumerated by the regulator itself: FDA's public establishment registration & listing database and GUDID contain every registrant with contact details. Incumbent regulatory-affairs consultancies bill $250-500/hr and target mid/large manufacturers, leaving thousands of micro manufacturers, spec developers, and software-as-a-medical-device startups unserved. Product: a $150-400/mo bureau that handles the annual registration cycle, listing updates, GUDID submissions, and MDR-clock tracking, acquired by cold outbound to the FDA's own registrant list (e.g., firms whose annual registration lapses or whose listings show stale data). INFERENCE: price points, lapse rates, and willingness of micro-registrants to outsource are inference; the public database and recurring duties are fact from FDA's regime, and signal 1394 shows new small-entrant pathways being created.

Instantiate the pattern with the WebPKI as the regulator-equivalent. The duty is recurring by construction (certs expire every 90 days, and industry ballots are shortening maximum lifetimes further); the penalty is loss of market access in its purest form — browsers hard-block the site; and the obligated class is perfectly enumerated in a public database: Certificate Transparency logs list every certificate, its expiry date, and its domains, from which contact addresses (WHOIS/RDAP, site scraping, security.txt) are derivable. Signal 1845 shows the free safety net (Let's Encrypt expiry emails) being withdrawn, orphaning a huge installed base of small operators with no compliance staff. Incumbent certificate-lifecycle-management vendors (Venafi/DigiCert-class) price for enterprises. Product: a $10-30/mo per-org 'renewal bureau' that watches a customer's names in CT, alerts on expiry AND on misissuance, and offers managed remediation (fix broken ACME automation, handle non-ACME certs) — sold by cold-emailing operators whose certs CT shows expiring in <30 days with no reissued replacement. INFERENCE: that LE-email-dependent operators will pay rather than fix automation themselves is inference; the CT enumerability and LE notification shutdown are supported by the signal and public record.

Transfer the pattern with Google Play as the 'regulator'. Google imposes recurring, evidentiary duties on every published app: annual target-API-level upgrades, and now Android 17's adaptive-UI mandate and enforced per-app memory limits that silently kill non-compliant apps (signal 841/845). The penalty is delisting/hiding from the Play Store — loss of market access, not a fine. The obligated class is fully enumerable: the Play Store itself is a public database of every app with its target SDK (visible via listing metadata) and a legally required developer contact email on every listing. Incumbent app-modernization consultancies price for large publishers, leaving hundreds of thousands of solo/small developers with aging apps unserved. Product: a $29-99/mo subscription that (a) continuously monitors a developer's apps against upcoming Play policy/API deadlines, (b) runs automated memory-limit and adaptive-UI conformance checks per Android 17 rules, and (c) ships prioritized remediation reports (optionally AI-generated patches). CAC collapses because you can crawl the store for apps still targeting old API levels and cold-email the published contact address with 'your app will be hidden on <date>'. INFERENCE: everything beyond the existence of the Android 17 requirements and public Play listings is inference, including willingness to pay.

Aave's packaged vaults let small fintechs offer on-chain yield without protocol integration (FACT, signal 868), which pushes many small, compliance-staff-free firms into money-transmitter/CASP territory (INFERENCE). The obligated class is publicly enumerated: FinCEN's MSB registration list is a downloadable public roster with business addresses, and EU MiCA authorization registers enumerate CASPs (INFERENCE from known regimes). Duties are recurring — MSB renewal every two years, state money-transmitter annual reports, travel-rule recordkeeping — and the sanction is deregistration or state-by-state loss of authorization: loss of market access, not a fine. Incumbent compliance firms price for exchanges and banks (signal 864 shows the institutional end being served by Swift-grade infrastructure). Instantiation: a $500–1,500/mo evidence-file subscription maintaining the registration, renewal, reporting, and travel-rule log stack for sub-20-person fintechs offering vault yield, sold by direct outreach to the newest entries on the public MSB/CASP rosters.

Small US nonprofits are a numerous, publicly enumerated obligated class: the IRS Exempt Organizations Business Master File is a free downloadable roster with EINs and addresses (INFERENCE from known IRS practice). Their recurring duties are existential and auto-enforced: three missed 990-N/990 filings trigger automatic revocation of tax-exempt status, and lapsed state charitable-solicitation renewals bar legal fundraising in most states (INFERENCE). Incumbents (accountants, Harbor-Compliance-style firms) serve the large end. Microsoft ending the free 365 Business Premium nonprofit grant (FACT, signal 1729) adds a synchronized platform duty on the same buyers: re-verification, license migration, and loss of Intune/Defender security posture. Instantiation: a $39–79/mo 'stay-alive file' subscription — 990 deadline management, state solicitation renewals, nonprofit-status re-verification for Microsoft/Google grants, and a low-cost security baseline replacing lost Premium features — sold by direct outreach to the IRS roster cross-referenced with the auto-revocation warning list.

The FDA's new class II special-controls pathway for opioid-impairment oxygenation monitors (FACT, signal 1394) is one of a stream of rules pulling small wearable/sensor/software teams into medical-device territory (INFERENCE). Once in, each maker owes recurring evidentiary duties: annual establishment registration and fee, device listing updates, MDR complaint files, UDI/GUDID records (INFERENCE from known FDA practice). The FDA publishes the complete Registration & Listing database with establishment contact info — a downloadable roster of the obligated class. Lapse means misbranding, import refusal, or removal from market: existential, not a fine. Incumbent regulatory consultancies bill $250+/hr and serve the large end. Instantiation: a productized $299–799/mo subscription that maintains the whole evidence file (registration renewal, listing accuracy, MDR log hygiene, special-controls documentation) for one-to-ten-person device makers, sold by direct outreach to the FDA roster filtered for small, recently registered establishments.

Google now functions as the pattern's 'regulator': Android 17 imposes recurring evidentiary duties on every published app (mandatory adaptive-UI compliance, per-app memory limits with silent kills — FACT from signals 845/841 — plus annual target-SDK bumps and Data Safety declarations — INFERENCE from known Play policy). Google Play is itself the public, enumerable registry of the obligated class: every listing exposes the developer's contact email, making the complete buyer list downloadable. The sanction is loss of market access (delisting / silent process kills), not a fine. Instantiation: a $49–99/mo subscription that maintains each small publisher's 'compliance file' — tracks their apps against every upcoming Play/OS deadline, runs memory-limit telemetry against Android 17 thresholds, files the recurring declarations, and alerts before delisting. Sold by direct outreach to scraped Play listings of apps still targeting old SDKs. Android 17's synchronized effective date compresses thousands of buyers into one demand spike, exactly as the pattern predicts.

India's DPDP Rules 2025 (signal 2012) convert informal data handling into recurring, documented duties — verifiable consent records, breach-notification timelines, Data Fiduciary notices — imposed extraterritorially on any SaaS with Indian users, including thousands of solo and micro-SaaS founders with no compliance staff. The stick is functionally market exclusion: penalties large enough to end a small company plus the practical inability to sell to Indian enterprise customers who demand DPDP attestation. Instantiation: a drop-in consent-record SDK plus a subscription dossier service that continuously assembles the evidence file (consent ledger, data-processing register, breach-response runbook with timestamps) so the founder can hand an auditor or enterprise buyer a current DPDP pack on demand. INFERENCE: enterprise procurement in India will start demanding DPDP evidence from vendors before regulators reach the long tail, making the buyer the founder chasing a deal, not just fearing a fine.

The DSA is being actively enforced (the Commission's breach finding against Meta, signal 2170), but its duties do not stop at VLOPs: every non-micro online platform serving the EU — niche marketplaces, forums, review sites, UGC apps — owes recurring evidentiary duties: annual transparency reports, statements of reasons filed to the Commission database for each moderation action, notice-and-action logs, and trader-traceability (KYBC) records for marketplaces. The obligated class is numerous, small, and staff-less; the stick is orders and ultimately exclusion from the EU market. Instantiation: a subscription tool that ingests the platform's moderation events via a lightweight API/webhook, auto-files statements of reasons, accumulates the audit trail, and generates the annual transparency report — an always-current DSA dossier. INFERENCE: enforcement attention will roll downhill from Meta to mid-tier and small platforms, and most small operators currently have no systematic records at all.